Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton

Brain Research

Volumn 1121, Issue 1, 2006, Pages 1-11

  Lauriat, Tara L ^a   Dracheva, Stella ^a,b   Kremerskothen, Joachim ^c   Duning, Kerstin ^c   Haroutunian, Vahram ^a,b   Buxbaum, Joseph D ^a   Hyde, Thomas M ^d   Kleinman, Joel E ^d   Alison McInnes, L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cerebellum; Gene expression; KIBRA; RT PCR; Schizophrenia; Yeast two hybrid

Indexed keywords

PROTEIN; PROTEIN HAX 1; PROTEIN INTS4; PROTEIN KIAA0513; PROTEIN KIBRA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TWO HYBRID SYSTEM; WESTERN BLOTTING;

ANIMALS; AUTOPSY; BRAIN; CEREBELLUM; DNA PRIMERS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 33750724136     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.08.099     Document Type: Article

References (37)

1. Andreasen N.C., O'Leary D.S., Cizadlo T., Arndt S., Rezai K., Ponto L.L., Watkins G.L., and Hichwa R.D. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9985-9990
2. Baillat D., Hakimi M.A., Naar A.M., Shilatifard A., Cooch N., and Shiekhattar R. Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 123 (2005) 265-276
3. Buckland P.R., Hoogendoorn B., Guy C.A., Coleman S.L., Smith S.K., Buxbaum J.D., Haroutunian V., and O'Donovan M.C. A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Biochim. Biophys. Acta 1690 (2004) 238-249
4. Buther K., Plaas C., Barnekow A., and Kremerskothen J. KIBRA is a novel substrate for protein kinase c zeta. Biochem. Biophys. Res. Commun. 317 (2004) 703-707
5. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., Cohen D., Ouelette G., and Realson J. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13675-13680
6. Cilenti L., Soundarapandian M.M., Kyriazis G.A., Stratico V., Singh S., Gupta S., Bonventre J.V., Alnemri E.S., and Zervos A.S. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J. Biol. Chem. 279 (2004) 50295-50301
7. Dracheva S., Marras S.A., Elhakem S.L., Kramer F.R., Davis K.L., and Haroutunian V. N-methyl-d-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am. J. Psychiatry 158 (2001) 1400-1410
8. Dufva M., Olsson M., and Rymo L. Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J Gen Virol. 82 (2001) 1581-1587
9. Eastwood S.L., Cotter D., and Harrison P.J. Cerebellar synaptic protein expression in schizophrenia. Neuroscience 105 (2001) 219-229
10. Eastwood S.L., Law A.J., Everall I.P., and Harrison P.J. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol. Psychiatry 8 (2003) 148-155
11. Gallagher A.R., Cedzich A., Gretz N., Somlo S., and Witzgall R. The polycystic kidney disease protein PKD2 interacts with hax-1, a protein associated with the actin cytoskeleton. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4017-4022
12. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E., and DiGiorgi Gerevini V. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57 (2000) 1061-1069
13. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., and Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4746-4751
14. Katsel P., Davis K.L., Gorman J.M., and Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr. Res. 77 (2005) 241-252
15. Kawaguchi Y., Nakajima K., Igarashi M., Morita T., Tanaka M., Suzuki M., Yokoyama A., Matsuda G., Kato K., Kanamori M., and Hirai K. Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J. Virol. 74 (2000) 10104-10111
16. Kremerskothen J., Plaas C., Buther K., Finger I., Veltel S., Matanis T., Liedtke T., and Barnekow A. Characterization of KIBRA, a novel WW domain-containing protein. Biochem. Biophys. Res. Commun. 300 (2003) 862-867
17. Kyosseva S.V. The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia. Cerebellum 3 (2004) 94-99
18. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- delta delta C(T)) method. Methods 25 (2001) 402-408
19. Marcelis M., Suckling J., Woodruff P., Hofman P., Bullmore E., and van Os J. Searching for a structural endophenotype in psychosis using computational morphometry. Psychiatry Res. 122 (2003) 153-167
20. Marchler-Bauer A., Anderson J.B., Cherukuri P.F., DeWeese-Scott C., Geer L.Y., Gwadz M., He S., Hurwitz D.I., Jackson J.D., Ke Z., Lanczycki C.J., Liebert C.A., Liu C., Lu F., Marchler G.H., Mullokandov M., Shoemaker B.A., Simonyan V., Song J.S., Thiessen P.A., Yamashita R.A., Yin J.J., Zhang D., and Bryant S.H. CDD: a conserved domain database for protein classification. Nucleic Acids Res. 33 (2005) D192-D196
21. Matsuda G., Nakajima K., Kawaguchi Y., Yamanashi Y., and Hirai K. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1. Microbiol. Immunol. 47 (2003) 91-99
22. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., Clair D.M., Muir W.J., Blackwood D.H., and Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9 (2000) 1415-1423
23. Mukaetova-Ladinska E.B., Hurt J., Honer W.G., Harrington C.R., and Wischik C.M. Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neurosci. Lett. 317 (2002) 161-165
24. Perlstein W.M., Dixit N.K., Carter C.S., Noll D.C., and Cohen J.D. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol. Psychiatry 53 (2003) 25-38
25. Purohit D.P., Perl D.P., Haroutunian V., Powchik P., Davidson M., and Davis K.L. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch. Gen. Psychiatry 55 (1998) 205-211
26. Rajkowska G., and Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. remapping of areas 9 and 46 using quantitative criteria. Cereb. Cortex 5 (1995) 307-322
27. Rayala S.K., den Hollander P., Manavathi B., Talukder A.H., Song C., Peng S., Barnekow A., Kremerskothen J., and Kumar R. Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian cells. J. Biol. Chem. 281 (2006) 19092-19099
28. Schmahmann J.D. An emerging concept. The cerebellar contribution to higher function. Arch. Neurol. 48 (1991) 1178-1187
29. Schmahmann J.D., and Sherman J.C. The cerebellar cognitive affective syndrome. Brain 121 Pt 4 (1998) 561-579
30. Serebriiskii, I., Golemis, E.A., 2000. Interaction trap at work. http://www.fccc.edu/research/labs/golemis/InteractionTrapInWork.html.
31. Sharp T.V., Wang H.W., Koumi A., Hollyman D., Endo Y., Ye H., Du M.Q., and Boshoff C. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J. Virol. 76 (2002) 802-816
32. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O'Neill F.A., Walsh D., and Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71 (2002) 337-348
33. Su A.I., Cooke M.P., Ching K.A., Hakak Y., Walker J.R., Wiltshire T., Orth A.P., Vega R.G., Sapinoso L.M., Moqrich A., Patapoutian A., Hampton G.M., Schultz P.G., and Hogenesch J.B. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4465-4470
34. Szeszko P.R., Gunning-Dixon F., Goldman R.S., Bates J., Ashtari M., Snyder P.J., Lieberman J.A., and Bilder R.M. Lack of normal association between cerebellar volume and neuropsychological functions in first-episode schizophrenia. Am. J. Psychiatry 160 (2003) 1884-1887
35. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) (RESEARCH0034)
36. Yedavalli V.S., Shih H.M., Chiang Y.P., Lu C.Y., Chang L.Y., Chen M.Y., Chuang C.Y., Dayton A.I., Jeang K.T., and Huang L.M. Human immunodeficiency virus type 1 vpr interacts with antiapoptotic mitochondrial protein HAX-1. J. Virol. 79 (2005) 13735-13746
37. Yin H., Morioka H., Towle C.A., Vidal M., Watanabe T., and Weissbach L. Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein. Cytokine 15 (2001) 122-137